| US 7,514,533 B2 | ||
| TNF-like secreted protein | ||
| Stephen Noel Fitzgerald, London (United Kingdom); Richard Joseph Fagan, London (United Kingdom); Christopher Benjamin Phelps, London (United Kingdom); Christine Power, Thoiry (France); Mark Ibberson, Gimel (Switzerland); and Melanie Yorke, Confignon (Switzerland) | ||
| Assigned to Ares Trading S.A., Aubonne (Switzerland) | ||
| Appl. No. 10/557,400 PCT Filed May 21, 2003, PCT No. PCT/GB03/02179 § 371(c)(1), (2), (4) Date Aug. 24, 2006, PCT Pub. No. WO2004/104040, PCT Pub. Date Dec. 02, 2004. |
||
| Prior Publication US 2007/0155958 A1, Jul. 05, 2007 | ||
| Int. Cl. C07K 17/00 (2006.01); C12P 21/08 (2006.01); A61K 38/00 (2006.01) | ||
| U.S. Cl. 530—350 [530/388.22; 514/12] | 6 Claims |
| 1. An isolated polypeptide selected from the group consisting of:
a) an isolated polypeptide consisting of SEQ ID NO: 10, SEQ ID NO: 14 or SEQ ID NO: 16; and
b) an isolated polypeptide comprising SEQ ID NO: 10 or SEQ ID NO:16.
|